OpenVSafe by OpenVAERS
Search V-safe

6J7-19305-66575

3 vaccinations 6 coded responses 28 check-ins 6 free-text entries 3 call cases
Sex
Female
Age at first dose
36-40
ZIP prefix
277 / NC
Registered
2021-01-11
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-18
    Dose 1 — Pfizer-BioNTech
  2. 2021-01-09
    Dose 2 — Pfizer-BioNTech
  3. 2021-01-11
    Registered in v-safe
  4. 2021-01-11
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain, Redness · Fever · Headache, Fatigue or tiredness · Be unable to work
    Adult check-in
  5. 2021-01-11
  6. 2021-01-12
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain, Redness, Itching · None
    Adult check-in
  7. 2021-01-13
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain, Redness, Itching · None
    Adult check-in
  8. 2021-01-14
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Redness, Itching · None
    Adult check-in
  9. 2021-01-15
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Itching · Fatigue or tiredness
    Adult check-in
  10. 2021-01-16
    Health check-in — day 7, dose 2
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  11. 2021-01-23
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  12. 2021-01-30
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  13. 2021-02-06
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  14. 2021-02-13
    Health check-in — day 35, dose 2
    Feeling: Fair
    Adult check-in
  15. 2021-02-20
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  16. 2021-04-10
    Survey response — 3 months, dose 2
    MedDRA: Asthma, Condition aggravated, Pre-existing disease — Feeling: Good · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, Hospitalization
    Free text: Bronchitis and asthma flare
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-04-10
    Report sent to call center — 3 months, dose 2
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  18. 2021-06-09
  19. 2021-07-10
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-09-28
    Dose 3 — Pfizer-BioNTech
  21. 2021-09-29
    Health check-in — days 1–6 daily, dose 3
    Feeling: Poor · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activities
    Adult check-in
  22. 2021-09-30
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Pain, Itching · Fever · Fatigue or tiredness
    Adult check-in
  23. 2021-10-01
    Survey response — days 1–6 daily, dose 3
    MedDRA: Hot flush — Feeling: Good · Site: Pain, Itching
    Free text: Hot flashes
    MedDRA releases: 2024-11 · check-in free text available
  24. 2021-10-02
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  25. 2021-10-03
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  26. 2021-10-04
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  27. 2021-10-05
    Health check-in — day 7, dose 3
    Feeling: Fair · Diarrhea
    Adult check-in
  28. 2021-10-12
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  29. 2021-10-19
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  30. 2021-10-26
    Survey response — day 28, dose 3
    MedDRA: Cough, Oropharyngeal pain — Feeling: Good
    Free text: Cough and sore throat
    MedDRA releases: 2024-11 · check-in free text available
  31. 2021-11-02
    Survey response — day 35, dose 3
    MedDRA: Nasopharyngitis — Feeling: Good
    Free text: Cold symptoms
    MedDRA releases: 2024-11 · check-in free text available
  32. 2021-11-09
    Survey response — day 42, dose 3
    MedDRA: Nasopharyngitis — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Cold symptoms
    MedDRA releases: 2024-11 · check-in free text available
  33. 2021-12-28
    Survey response — 3 months, dose 3
    MedDRA: Asthma, Pre-existing disease — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit
    Free text: Asthma exacerbation
    MedDRA releases: 2024-11 · check-in free text available
  34. 2021-12-28
    Report sent to call center — 3 months, dose 3
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Emergency room or emergency department visit · 1 call case(s)
  35. 2022-01-03
  36. 2022-03-29
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in
  37. 2022-09-28
    Health check-in — 12 months, dose 3
    Feeling: Fair
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12020-12-18Pfizer-BioNTech
22021-01-09Pfizer-BioNTech
32021-09-28Pfizer-BioNTech No

Call center

ReportedOutcomeVAERS-related outcome
2021-01-11 priority 2/3
2021-04-10 Unsuccessful
2021-12-28 Unsuccessful

Free text

Release 7 — 3 months, dose 2

2021-04-10

Symptoms: Bronchitis and asthma flare

Release 9 — days 1–6 daily, dose 3

2021-10-01

Systemic reaction (other): Hot flashes

Release 10 — day 28, dose 3

2021-10-26

Symptoms: Cough and sore throat

Release 10 — day 35, dose 3

2021-11-02

Symptoms: Cold symptoms

Release 10 — day 42, dose 3

2021-11-09

Symptoms: Cold symptoms

Release 10 — 3 months, dose 3

2021-12-28

Symptoms: Asthma exacerbation

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAsthma ✓ ✓ ✓
SDCondition aggravated ✓ ✓ ✓
SDCough · · ✓
SDNasopharyngitis · · ✓
SDOropharyngeal pain · · ✓
SDPre-existing disease ✓ ✓ ✓
SROHot flush · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release